You have 9 free searches left this month | for more free features.

Advanced solid tumor

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in New Taipei City (solid organ malignancies treatment)

Recruiting
  • Cancer
  • solid organ malignancies treatment
  • New Taipei City, Taiwan
    TuCheng Hospital
May 18, 2022

Different Surgical Approaches for Giant Pituitary Adenomas

Recruiting
  • Surgery
  • Pituitary Adenoma
  • Two different approaches
  • Chongqing, Chongqing, China
  • +12 more
Oct 13, 2022

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and

Completed
  • Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
  • APR-246
  • Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
  • Los Angeles, California
  • +54 more
Sep 20, 2022

Tumors Trial in New York (NY-ESO-1 Protein Vaccine)

Completed
  • Tumors
  • NY-ESO-1 Protein Vaccine
  • New York, New York
  • +1 more
Nov 29, 2021

Tumor Trial in China (Anlotinib)

Completed
  • Tumor
  • Beijing, Beijing, China
  • +9 more
May 20, 2019

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Breast Tumor, Lymphedema Trial in Edmonton (Standard Care, Exercise and Compression Garment, Exercise and Adjustable Compression

Recruiting
  • Breast Neoplasm
  • Lymphedema
  • Standard Care
  • +2 more
  • Edmonton, Alberta, Canada
    University of Alberta/ Cross Cancer Institute
Nov 29, 2022

Colon Cancer Trial in Italy (Conventional Right hemicolectomy (Non-CME), Right hemicolectomy with CME+CVL)

Recruiting
  • Colon Cancer
  • Conventional Right hemicolectomy (Non-CME)
  • Right hemicolectomy with CME+CVL
  • Grosseto, Arezzo, Italy
  • +13 more
Nov 11, 2022

s From HIV Infection, KSHV Infection, Viral-Related

Recruiting
  • HIV
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

    Active, not recruiting
    • Melanoma
    • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
    • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
    • Toulouse, France
      Institut Claudius Regaud IUCT-ONCOPOLE
    Nov 18, 2022

    Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

    Recruiting
    • Breast Carcinoma
    • +10 more
    • Computed Tomography
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Nov 29, 2022

    Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Houston

    Active, not recruiting
    • Malignant Solid Neoplasm
    • +2 more
    • 3-Dimensional Conformal Radiation Therapy
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    Nov 22, 2022

    Breast Cancer Trial in Netherlands (Carbo/cyclo, Carbo/cyclo + atezolizumab, Paclitaxel)

    Recruiting
    • Breast Cancer
    • Alkmaar, Netherlands
    • +48 more
    Mar 21, 2022

    Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    May 5, 2023

    Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)

    Completed
    • Covid19
    • +3 more
    • SARS-COV2 Pfizer Vaccine
    • Tucson, Arizona
      University of Arizona
    May 19, 2022

    Breast Cancer, Lung Cancer, Solid Tumor Trial in Sacramento (Abraxane, Alimta)

    Terminated
    • Breast Cancer
    • +2 more
    • Sacramento, California
      University of California Davis Cancer Center
    Jan 5, 2018

    Biliary Tract Cancer, Cholangiocarcinoma Trial in Nanjing (SHR-1210+GEMOX)

    Completed
    • Biliary Tract Cancer
    • Cholangiocarcinoma
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Oct 27, 2021

    Esophageal Squamous Cell Carcinoma Trial in Worldwide (Durvalumab, Placebo, cisplatin + fluorouracil)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Tucson, Arizona
    • +165 more
    Jan 18, 2023

    Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 2, 2023

    Cancer Trial in Stockholm (Karonudib)

    Unknown status
    • Cancer
    • Stockholm, Sweden
      Karolinska University Hospital
    Feb 3, 2021

    Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)

    Recruiting
    • Pancreatic Cancer Non-resectable
    • stereotactic ablative radiotherapy
    • Amsterdam, Noord-Holland, Netherlands
    • +1 more
    Feb 22, 2022

    Liver and Spleen Stiffness Measured by TE and 2D-SWE for

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital, Sun Yat-sen University
    Nov 16, 2023

    Peritoneal Carcinomatosis, Gastrointestinal Peritoneal Carcinomatosis Trial in Orange (Biospecimen Collection (Blood,

    Not yet recruiting
    • Peritoneal Carcinomatosis
    • Gastrointestinal Peritoneal Carcinomatosis
    • Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples)
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    May 2, 2023